Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:alpha-D-galactose
go back to main search page
Accession:CHEBI:28061 term browser browse the term
Definition:D-Galactopyranose having alpha-configuration at the anomeric centre.
Synonyms:related_synonym: Formula=C6H12O6;   Gal-alpha;   InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1;   InChIKey=WQZGKKKJIJFFOK-PHYPRBDBSA-N;   SMILES=OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O;   alpha-D-Gal;   alpha-D-Galactopyranose
 alt_id: CHEBI:10231;   CHEBI:22373;   CHEBI:42741
 xref: Beilstein:1281609;   CAS:26566-61-0;   CAS:3646-73-9;   CAS:59-23-4;   Drug_Central:1271;   GlyTouCan:G09546QO;   Gmelin:648638;   KEGG:C00984;   KEGG:C01582;   KEGG:D04291;   KNApSAcK:C00001119
 xref_mesh: MESH:D005690
 xref: PDBeChem:GLA;   PMID:17991151;   PMID:19443021;   PMID:25568069;   PMID:31537530;   PMID:7521740;   PMID:8154046;   Reaxys:1281609
 cyclic_relationship: is_enantiomer_of CHEBI:42905


show annotations for term's descendants           Sort by:
 
alpha-D-galactose term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase increases activity
multiple interactions
ISO Galactose results in increased activity of ACHE protein
catalpol inhibits the reaction [Galactose results in increased activity of ACHE protein]
CTD PMID:23612000 NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
JBrowse link
G Ager advanced glycosylation end product-specific receptor increases expression ISO Galactose results in increased expression of AGER mRNA; Galactose results in increased expression of AGER protein CTD PMID:22687555 NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
JBrowse link
G Aif1 allograft inflammatory factor 1 increases expression
multiple interactions
ISO Galactose results in increased expression of AIF1 protein
lycopene inhibits the reaction [Galactose results in increased expression of AIF1 protein]
CTD PMID:28974442 NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B multiple interactions
increases expression
ISO protocatechuic acid inhibits the reaction [Galactose results in increased expression of AKR1B3 mRNA] CTD PMID:22687555 NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
JBrowse link
G Aox1 aldehyde oxidase 1 increases expression
multiple interactions
ISO Galactose results in increased expression of AOX1 mRNA
sodium bisulfide inhibits the reaction [Galactose results in increased expression of AOX1 mRNA]
CTD PMID:23274001 NCBI chr 9:64,929,682...65,007,872
Ensembl chr 9:64,929,721...65,007,870
JBrowse link
G Atf4 activating transcription factor 4 multiple interactions ISO [Galactose co-treated with Glucose deficiency] promotes the reaction [leflunomide results in increased expression of ATF4 protein] CTD PMID:29427785 NCBI chr 7:121,480,723...121,482,781
Ensembl chr 7:121,480,723...121,482,772
JBrowse link
G Atg7 autophagy related 7 decreases expression
multiple interactions
EXP
ISO
Galactose results in decreased expression of ATG7 protein
MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein]
CTD PMID:28302704 NCBI chr 4:146,570,113...146,777,093
Ensembl chr 4:146,598,413...146,777,124
JBrowse link
G Atox1 antioxidant 1 copper chaperone decreases expression
multiple interactions
ISO Galactose results in decreased expression of ATOX1 mRNA
sodium bisulfide inhibits the reaction [Galactose results in decreased expression of ATOX1 mRNA]
CTD PMID:23274001 NCBI chr10:40,790,850...40,805,886
Ensembl chr10:40,790,845...40,805,941
JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 NCBI chr18:74,156,553...74,164,490
Ensembl chr18:74,156,553...74,164,495
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression
ISO
EXP
Phycocyanin inhibits the reaction [Galactose results in increased expression of BAX protein]
Saponins inhibits the reaction [Galactose results in increased expression of BAX protein]
CTD PMID:23036742, PMID:25892055 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
decreases expression
ISO
EXP
Phycocyanin inhibits the reaction [Galactose results in decreased expression of BCL2 protein]
Saponins inhibits the reaction [Galactose results in decreased expression of BCL2 protein]
CTD PMID:23036742, PMID:25892055 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
JBrowse link
G Bdnf brain-derived neurotrophic factor decreases expression
multiple interactions
ISO Galactose results in decreased expression of BDNF mRNA; Galactose results in decreased expression of BDNF protein
lycopene inhibits the reaction [Galactose results in decreased expression of BDNF mRNA]; lycopene inhibits the reaction [Galactose results in decreased expression of BDNF protein]
CTD PMID:28974442 NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
JBrowse link
G Becn1 beclin 1 multiple interactions
decreases expression
EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in decreased expression of BECN1 protein]
Galactose results in decreased expression of BECN1 protein
CTD PMID:25997894, PMID:28302704 NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
JBrowse link
G Casp3 caspase 3 increases cleavage
multiple interactions
increases activity
ISO
EXP
Galactose results in increased cleavage of CASP3 protein
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]
pioglitazone inhibits the reaction [Galactose results in increased activity of CASP3 protein]
Phycocyanin inhibits the reaction [Galactose results in increased cleavage of CASP3 protein]
CTD PMID:23036742, PMID:23795773, PMID:25997894 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casp9 caspase 9 multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] CTD PMID:25997894 NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
JBrowse link
G Cat catalase increases activity
multiple interactions
EXP Galactose results in increased activity of CAT protein
Quercetin inhibits the reaction [Galactose results in increased activity of CAT protein]
CTD PMID:17211565 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
JBrowse link
G Ccn2 cellular communication network factor 2 increases expression
multiple interactions
EXP Galactose results in increased expression of CCN2 protein
fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of CCN2 protein]
CTD PMID:30367734 NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
JBrowse link
G Chat choline O-acetyltransferase multiple interactions
decreases activity
ISO catalpol inhibits the reaction [Galactose results in decreased activity of CHAT protein] CTD PMID:23612000 NCBI chr16:8,576,858...8,686,131
Ensembl chr16:8,577,840...8,686,131
JBrowse link
G Chrm1 cholinergic receptor, muscarinic 1 multiple interactions
decreases expression
ISO catalpol inhibits the reaction [Galactose results in decreased expression of CHRM1 protein] CTD PMID:23612000 NCBI chr 1:224,869,087...224,885,101
Ensembl chr 1:224,882,439...224,884,205
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
increases expression
ISO [Galactose co-treated with Glucose deficiency] promotes the reaction [leflunomide results in increased expression of DDIT3 protein]; Phycocyanin inhibits the reaction [Galactose results in increased expression of DDIT3 protein] CTD PMID:23036742, PMID:29427785 NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
JBrowse link
G Dnm1l dynamin 1-like increases expression
multiple interactions
ISO
EXP
Galactose results in increased expression of DNM1L protein
MIR34A mRNA promotes the reaction [Galactose results in increased expression of DNM1L protein]
CTD PMID:28302704 NCBI chr11:88,830,968...88,882,271
Ensembl chr11:88,830,957...88,880,198
JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions
increases expression
EXP fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of FGF2 protein] CTD PMID:30367734 NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
JBrowse link
G Galk1 galactokinase 1 multiple interactions
increases metabolic processing
ISO [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate CTD PMID:20696150 NCBI chr10:104,560,322...104,564,499
Ensembl chr10:104,560,303...104,564,480
JBrowse link
G Gap43 growth associated protein 43 decreases expression
multiple interactions
ISO Galactose results in decreased expression of GAP43 mRNA
Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA]
CTD PMID:16707173 NCBI chr11:58,624,198...58,717,916
Ensembl chr11:58,624,198...58,717,914
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit decreases expression
multiple interactions
EXP Galactose results in decreased expression of GCLC mRNA
Saponins inhibits the reaction [Galactose results in decreased expression of GCLC mRNA]
CTD PMID:25892055 NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
JBrowse link
G Glo1 glyoxalase 1 multiple interactions ISO Galactose results in decreased expression of and results in decreased activity of GLO1 protein; protocatechuic acid inhibits the reaction [Galactose results in decreased expression of and results in decreased activity of GLO1 protein] CTD PMID:22687555 NCBI chr20:9,273,589...9,291,608
Ensembl chr20:9,273,594...9,291,610
JBrowse link
G Gss glutathione synthetase multiple interactions
decreases expression
ISO sodium bisulfide inhibits the reaction [Galactose results in decreased expression of GSS mRNA] CTD PMID:23274001 NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557
JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions ISO Galactose affects the reaction [Fusaric Acid affects the expression of HIF1A protein] CTD PMID:31654802 NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
decreases expression
EXP
ISO
Saponins inhibits the reaction [Galactose results in decreased expression of HMOX1 mRNA]
lycopene inhibits the reaction [Galactose results in decreased expression of HMOX1 mRNA]
CTD PMID:25892055, PMID:28974442 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression
ISO Phycocyanin inhibits the reaction [Galactose results in increased expression of HSPA5 protein] CTD PMID:23036742 NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
JBrowse link
G Ifnb1 interferon beta 1 multiple interactions ISO [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased expression of IFNB1 protein; scoparone inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased expression of IFNB1 protein] CTD PMID:23535186 NCBI chr 5:106,865,192...106,865,746
Ensembl chr 5:106,865,192...106,865,746
JBrowse link
G Il1b interleukin 1 beta increases expression
multiple interactions
increases secretion
ISO Galactose results in increased expression of IL1B protein
catalpol inhibits the reaction [Galactose results in increased expression of IL1B protein]; lycopene inhibits the reaction [Galactose results in increased expression of IL1B protein]; protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL1B protein]
CTD PMID:22687555, PMID:23612000, PMID:28974442 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
JBrowse link
G Il6 interleukin 6 multiple interactions
increases secretion
ISO [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL6 protein; protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL6 protein]; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL6 protein]
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside F1 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside M1 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside Rg3 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside Rh1 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside Rh2 inhibits the reaction [Galactose results in increased secretion of IL6 protein]
CTD PMID:22687555, PMID:23535186, PMID:29412148 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Irf3 interferon regulatory factor 3 multiple interactions ISO [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased phosphorylation of IRF3 protein; scoparone inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased phosphorylation of IRF3 protein] CTD PMID:23535186 NCBI chr 1:100,992,244...100,997,202
Ensembl chr 1:100,992,405...100,997,198
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] affects the localization of and results in increased expression of JUN protein modified form; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] affects the localization of and results in increased expression of JUN protein modified form] CTD PMID:23535186 NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
JBrowse link
G Lct lactase increases hydrolysis EXP LCT protein results in increased hydrolysis of Galactose CTD PMID:14701853 NCBI chr13:44,998,414...45,040,593
Ensembl chr13:44,998,414...45,040,593
JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation
multiple interactions
EXP Galactose results in increased phosphorylation of MAPK1 protein
fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased phosphorylation of MAPK1 protein]
CTD PMID:30367734 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation
multiple interactions
EXP Galactose results in increased phosphorylation of MAPK3 protein
fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased phosphorylation of MAPK3 protein]
CTD PMID:30367734 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Mfn2 mitofusin 2 increases expression
multiple interactions
EXP
ISO
Galactose results in increased expression of MFN2 protein
MIR34A mRNA promotes the reaction [Galactose results in increased expression of MFN2 protein]
CTD PMID:28302704 NCBI chr 5:164,684,244...164,715,414
Ensembl chr 5:164,684,509...164,714,145
JBrowse link
G Mir34a microRNA 34a increases expression
multiple interactions
EXP
ISO
Galactose results in increased expression of MIR34A mRNA
MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of DNM1L protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of MFN2 protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of SQSTM1 protein]
CTD PMID:28302704 NCBI chr 5:167,092,491...167,092,592
Ensembl chr 5:167,092,491...167,092,592
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions
increases activity
EXP fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased activity of MMP2 protein] CTD PMID:30367734 NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of and results in increased activity of MMP9 protein]; Galactose results in increased expression of and results in increased activity of MMP9 protein CTD PMID:30367734 NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of COX1 protein CTD PMID:25997894 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
JBrowse link
G Mt-nd4 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 affects metabolic processing ISO ND4 protein affects the metabolism of Galactose CTD PMID:8662757 NCBI chr MT:10,160...11,537
Ensembl chr MT:10,160...11,537
JBrowse link
G Mt-nd6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 affects metabolic processing ISO ND6 protein affects the metabolism of Galactose CTD PMID:9707444 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions ISO [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of MYD88 protein; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of MYD88 protein] CTD PMID:23535186 NCBI chr 8:128,022,512...128,027,462
Ensembl chr 8:128,022,473...128,026,841
JBrowse link
G Ndufb8 NADH:ubiquinone oxidoreductase subunit B8 multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of NDUFB8 protein CTD PMID:25997894 NCBI chr 1:264,298,671...264,303,712
Ensembl chr 1:264,298,669...264,303,762
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 affects localization
multiple interactions
EXP Galactose affects the localization of NFE2L2 protein
Saponins inhibits the reaction [Galactose affects the localization of NFE2L2 protein]
CTD PMID:25892055 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 increases expression ISO Galactose results in increased expression of NFKB1 mRNA; Galactose results in increased expression of NFKB1 protein CTD PMID:22687555 NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
increases expression
increases activity
ISO Oligopeptides inhibits the reaction [Galactose results in increased activity of NOS2 protein]
Galactose results in increased expression of NOS2 mRNA
CTD PMID:23796539, PMID:28974442 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions
decreases expression
EXP
ISO
Saponins inhibits the reaction [Galactose results in decreased expression of NQO1 mRNA]
lycopene inhibits the reaction [Galactose results in decreased expression of NQO1 mRNA]
CTD PMID:25892055, PMID:28974442 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
JBrowse link
G Oat ornithine aminotransferase multiple interactions EXP Galactose inhibits the reaction [Cyclic AMP results in increased activity of OAT protein] CTD PMID:2827574 NCBI chr 1:204,562,289...204,582,070
Ensembl chr 1:204,562,289...204,582,070
JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 multiple interactions ISO Galactose affects the reaction [Fusaric Acid results in increased expression of PDK1 protein] CTD PMID:31654802 NCBI chr 3:58,530,870...58,561,494
Ensembl chr 3:58,530,870...58,558,027
JBrowse link
G Pkm pyruvate kinase M1/2 multiple interactions ISO Galactose affects the reaction [Fusaric Acid results in increased expression of PKM mRNA] CTD PMID:31654802 NCBI chr 8:64,480,963...64,502,957
Ensembl chr 8:64,481,172...64,502,722
JBrowse link
G Plau plasminogen activator, urokinase increases expression
multiple interactions
EXP Galactose results in increased expression of PLAU protein
fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of PLAU protein]
CTD PMID:30367734 NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
JBrowse link
G Ppargc1a PPARG coactivator 1 alpha decreases expression EXP Galactose results in decreased expression of PPARGC1A protein CTD PMID:28302704 NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
ISO Galactose results in increased expression of and results in increased activity of PTGS2 protein; lycopene inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 protein] CTD PMID:22687555, PMID:28974442 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
affects localization
increases expression
ISO [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] affects the localization of and results in increased expression of RELA protein; Galactose results in increased expression of and results in increased activity of RELA protein; protocatechuic acid inhibits the reaction [Galactose results in increased expression of and results in increased activity of RELA protein]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA protein]; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] affects the localization of and results in increased expression of RELA protein]
ginsenoside F1 inhibits the reaction [Galactose affects the localization of RELA protein]; SB 203580 inhibits the reaction [Galactose affects the localization of RELA protein]
Galactose results in increased expression of RELA mRNA; Galactose results in increased expression of RELA protein
CTD PMID:22687555, PMID:23535186, PMID:29412148 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
JBrowse link
G Sirt1 sirtuin 1 multiple interactions
decreases expression
EXP
ISO
Saponins inhibits the reaction [Galactose results in decreased expression of SIRT1 protein]
[Glucose deficiency co-treated with Galactose co-treated with Amino Acids co-treated with Pyruvic Acid] inhibits the reaction [resveratrol results in increased expression of SIRT1 protein]
CTD PMID:25892055, PMID:27358235, PMID:29426000 NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
JBrowse link
G Slc2a2 solute carrier family 2 member 2 increases transport ISO SLC2A2 protein results in increased transport of Galactose CTD PMID:8457197 NCBI chr 2:114,413,427...114,445,418
Ensembl chr 2:114,413,410...114,445,395
JBrowse link
G Slc2a3 solute carrier family 2 member 3 increases transport
multiple interactions
ISO SLC2A3 protein results in increased transport of Galactose
Galactose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose]; Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose]
CTD PMID:8457197 NCBI chr 4:155,549,991...155,626,018
Ensembl chr 4:155,408,233...155,631,856
JBrowse link
G Slc5a1 solute carrier family 5 member 1 multiple interactions
affects transport
ISO Galactose inhibits the reaction [[Sodium co-treated with SLC5A1 protein] results in increased uptake of methylglucoside]
SLC5A1 protein affects the transport of Galactose
CTD PMID:16300400, PMID:17288452 NCBI chr14:82,910,448...82,975,303
Ensembl chr14:82,909,981...82,975,263
JBrowse link
G Sod2 superoxide dismutase 2 decreases expression
multiple interactions
EXP Galactose results in decreased expression of SOD2 mRNA
Saponins inhibits the reaction [Galactose results in decreased expression of SOD2 mRNA]
CTD PMID:25892055 NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
JBrowse link
G Sord sorbitol dehydrogenase increases expression ISO Galactose results in increased expression of SORD mRNA CTD PMID:22687555 NCBI chr 3:114,176,127...114,207,368
Ensembl chr 3:114,176,309...114,207,366
JBrowse link
G Sp1 Sp1 transcription factor multiple interactions
increases expression
EXP fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of SP1 protein] CTD PMID:30367734 NCBI chr 7:144,014,173...144,044,635
Ensembl chr 7:144,014,173...144,044,629
JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
increases expression
ISO
EXP
Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]]; Metformin inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of SQSTM1 protein] CTD PMID:28302704, PMID:29426000 NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 increases expression ISO Galactose results in increased expression of SREBF1 mRNA CTD PMID:10913129 NCBI chr10:46,570,996...46,593,021
Ensembl chr10:46,570,996...46,593,009
JBrowse link
G Tfam transcription factor A, mitochondrial multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of TFAM protein CTD PMID:25997894 NCBI chr20:18,594,057...18,606,106
Ensembl chr20:18,594,037...18,606,151
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
increases expression
EXP fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of TGFB1 protein] CTD PMID:30367734 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
JBrowse link
G Ticam1 toll-like receptor adaptor molecule 1 multiple interactions ISO [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TICAM1 protein; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TICAM1 protein] CTD PMID:23535186 NCBI chr 9:10,780,185...10,790,280 JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TLR4 protein; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TLR4 protein] CTD PMID:23535186 NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
increases secretion
ISO [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TNF protein; catalpol inhibits the reaction [Galactose results in increased expression of TNF protein]; lycopene inhibits the reaction [Galactose results in increased expression of TNF protein]; protocatechuic acid inhibits the reaction [Galactose results in increased secretion of TNF protein]; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TNF protein] CTD PMID:22687555, PMID:23535186, PMID:23612000, PMID:28974442 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression
ISO
EXP
Phycocyanin inhibits the reaction [Galactose results in increased expression of TP53 protein]
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]
CTD PMID:23036742, PMID:25997894, PMID:29426000 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
JBrowse link
G Txnip thioredoxin interacting protein multiple interactions
increases expression
ISO Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein]]; Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein] CTD PMID:29426000 NCBI chr 2:198,683,168...198,686,971
Ensembl chr 2:198,683,159...198,686,974
JBrowse link
G Txnrd1 thioredoxin reductase 1 decreases expression
multiple interactions
ISO Galactose results in decreased expression of TXNRD1 mRNA
sodium bisulfide inhibits the reaction [Galactose results in decreased expression of TXNRD1 mRNA]
CTD PMID:23274001 NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400
JBrowse link
1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression ISO KRN 7000 results in increased expression of CXCL10 protein CTD PMID:15867097 NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
JBrowse link
G Il12b interleukin 12B increases expression ISO KRN 7000 results in increased expression of IL12B protein CTD PMID:15867097 NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085
JBrowse link
alpha-D-galactose 1-phosphate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Galk1 galactokinase 1 multiple interactions ISO [Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein] which results in decreased abundance of galactose-1-phosphate; [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate CTD PMID:20696150 NCBI chr10:104,560,322...104,564,499
Ensembl chr10:104,560,303...104,564,480
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19810
    role 19758
      biological role 19758
        biochemical role 19304
          metabolite 19285
            fundamental metabolite 12625
              galactose 166
                D-galactose 166
                  D-galactopyranose 166
                    alpha-D-galactose 77
                      1-O-(4-O-\{3-[4-(trifluoromethyl)phenyl]propyl\}-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(4-O-allyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(4-O-benzyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(4-O-propyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(6-acetamido-6-deoxy-alpha-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(10-phenyldecanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(11-phenylundecanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(21-phenylhenicosanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(25-phenylpentacosanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(6-phenylhexanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(7-phenylheptanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(8-phenyloctanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(9-phenylnonanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[11-(4-fluorophenyl)undecanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[11-(4-methoxyphenyl)undecanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[6-(4-methoxyphenyl)hexanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[8-(4-fluorophenyl)octanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[8-(4-methoxyphenyl)octanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[8-(4-trifluoromethyl)phenyloctanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-\{11-[4-(trifluoromethyl)phenyl]undecanoyl\}phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-\{6-[4-(trifluoromethyl)phenyl]hexanoyl\}phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-dodecanoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylsphinganine 0
                      1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-nonanoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-octanoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-pamitoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-tetracosanyl-2-aminononane-1,3,4-triol 0
                      1-O-(alpha-D-galactopyranosyl)-N-tetracosanylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-tetradecanoylphytosphingosine 0
                      1-O-(alpha-D-galactosyl)-N-decanoylphytosphingosine 0
                      1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine + 2
                      1-O-(alpha-D-galactosyl)-N-undecanoylphytosphingosine 0
                      1-O-[4-O-(2-adamantylethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(3,4-dichlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(3,4-difluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(3-phenylpropyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-chlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-fluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-methylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-phenylbutyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-tert-butylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(5-phenylpentyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(6-phenylhexyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(cyclobutylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(cyclopropylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactopyranosyl]-N-hexacosanoylsphinganine 0
                      1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(3,4-dichlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-chlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-methoxyphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-methylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-tert-butylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      2-deoxy-2-fluoro-alpha-D-galactose 0
                      GlcpN-(1->1)-alpha-D-Galp 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-13-phenyltridecan-2-yl]hexacosanamide 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-8-phenyloctan-2-yl]hexacosanamide 0
                      N-[11-([1,1'-biphenyl]-4-yl)undecanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      N-[6-(4-fluorophenyl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      N-[6-([1,1'-biphenyl]-4-yl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      N-[8-([1,1'-biphenyl]-4-yl)octanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      alpha-D-Gal-(1->3)-alpha-D-Gal-OMe 0
                      alpha-D-Gal-(1->4)-alpha-D-Gal-OMe 0
                      alpha-D-Galf-(1->2)-alpha-D-Galp 0
                      alpha-D-Galp-(1->2)-alpha-D-Glcp 0
                      alpha-D-Galp-(1->2)-alpha-D-Manp 0
                      alpha-D-Galp-(1->2)-beta-D-Glcp-(1->4)-beta-D-Glcp 0
                      alpha-D-Galp-(1->3)-D-Glcp 0
                      alpha-D-Galp-(1->3)-alpha-D-GlcpNAc 0
                      alpha-D-Galp-(1->3)-alpha-D-Manp 0
                      alpha-D-Galp-(1->3)-beta-D-GlcpNAc + 0
                      alpha-D-Galp-(1->4)-D-Gal-OH 0
                      alpha-D-Galp-(1->4)-alpha-D-Glcp 0
                      alpha-D-Galp-(1->4)-alpha-L-Fucp 0
                      alpha-D-Galp-(1->4)-beta-D-Glcp + 0
                      alpha-D-Galp-(1->4)-beta-D-GlcpNAc 0
                      alpha-D-Galp-(1->6)-D-Glc-OH 0
                      alpha-D-Galp-(1->6)-alpha-D-Galp 0
                      alpha-D-Galp-(1->6)-alpha-D-Glcp 0
                      alpha-D-Galp-(1->6)-beta-D-Manp 0
                      alpha-D-GalpNAc-(1->3)-alpha-D-Galp + 0
                      alpha-D-Glcp-(1->3)-alpha-D-Galp + 0
                      alpha-D-Glcp-(1->6)-D-Gal-OH 0
                      alpha-D-Glcp-(1->6)-alpha-D-Galp + 0
                      alpha-D-GlcpN-(1->1)-alpha-D-Galp 0
                      alpha-D-Manp-(1->2)-alpha-D-Galp 0
                      alpha-D-galactose 1-phosphate 1
                      alpha-D-galactoside + 0
                      alpha-D-galactosyl group + 0
                      alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1<->1')-ceramide 0
                      alpha-L-Fucp-(1->2)-alpha-D-Galp 0
                      alpha-L-Fucp-(1->3)-alpha-D-Galp + 0
                      alpha-L-Fucp-(1->6)-alpha-D-Galp 0
                      beta-D-Galf-(1->3)-alpha-D-Galp 0
                      beta-D-Glcp-(1->3)-alpha-D-Galp 0
                      beta-D-Glcp-(1->6)-alpha-D-Galp 0
                      beta-L-Fucp-(1->2)-alpha-D-Galp 0
                      beta-L-Fucp-(1->3)-alpha-D-Galp 0
                      beta-L-Fucp-(1->4)-alpha-D-Galp + 0
                      penta-O-acetyl-alpha-D-galactose 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19810
    subatomic particle 19808
      composite particle 19808
        hadron 19808
          baryon 19808
            nucleon 19808
              atomic nucleus 19808
                atom 19808
                  main group element atom 19696
                    p-block element atom 19696
                      carbon group element atom 19599
                        carbon atom 19588
                          organic molecular entity 19588
                            heteroorganic entity 19175
                              organochalcogen compound 18886
                                organooxygen compound 18809
                                  carbohydrates and carbohydrate derivatives 12196
                                    carbohydrate 12196
                                      monosaccharide 4034
                                        aldose 2550
                                          aldohexose 2193
                                            D-aldohexose 2187
                                              D-galactose 166
                                                D-galactopyranose 166
                                                  alpha-D-galactose 77
                                                    1-O-(4-O-\{3-[4-(trifluoromethyl)phenyl]propyl\}-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(4-O-allyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(4-O-benzyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(4-O-propyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(6-acetamido-6-deoxy-alpha-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(10-phenyldecanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(11-phenylundecanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(21-phenylhenicosanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(25-phenylpentacosanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(6-phenylhexanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(7-phenylheptanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(8-phenyloctanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(9-phenylnonanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[11-(4-fluorophenyl)undecanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[11-(4-methoxyphenyl)undecanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[6-(4-methoxyphenyl)hexanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[8-(4-fluorophenyl)octanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[8-(4-methoxyphenyl)octanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[8-(4-trifluoromethyl)phenyloctanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-\{11-[4-(trifluoromethyl)phenyl]undecanoyl\}phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-\{6-[4-(trifluoromethyl)phenyl]hexanoyl\}phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-dodecanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylsphinganine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-nonanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-octanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-pamitoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-tetracosanyl-2-aminononane-1,3,4-triol 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-tetracosanylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-tetradecanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactosyl)-N-decanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine + 2
                                                    1-O-(alpha-D-galactosyl)-N-undecanoylphytosphingosine 0
                                                    1-O-[4-O-(2-adamantylethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(3,4-dichlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(3,4-difluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(3-phenylpropyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-chlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-fluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-methylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-phenylbutyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-tert-butylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(5-phenylpentyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(6-phenylhexyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(cyclobutylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(cyclopropylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactopyranosyl]-N-hexacosanoylsphinganine 0
                                                    1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(3,4-dichlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-chlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-methoxyphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-methylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-tert-butylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    2-deoxy-2-fluoro-alpha-D-galactose 0
                                                    GlcpN-(1->1)-alpha-D-Galp 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-13-phenyltridecan-2-yl]hexacosanamide 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-8-phenyloctan-2-yl]hexacosanamide 0
                                                    N-[11-([1,1'-biphenyl]-4-yl)undecanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    N-[6-(4-fluorophenyl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    N-[6-([1,1'-biphenyl]-4-yl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    N-[8-([1,1'-biphenyl]-4-yl)octanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    alpha-D-Gal-(1->3)-alpha-D-Gal-OMe 0
                                                    alpha-D-Gal-(1->4)-alpha-D-Gal-OMe 0
                                                    alpha-D-Galf-(1->2)-alpha-D-Galp 0
                                                    alpha-D-Galp-(1->2)-alpha-D-Glcp 0
                                                    alpha-D-Galp-(1->2)-alpha-D-Manp 0
                                                    alpha-D-Galp-(1->2)-beta-D-Glcp-(1->4)-beta-D-Glcp 0
                                                    alpha-D-Galp-(1->3)-D-Glcp 0
                                                    alpha-D-Galp-(1->3)-alpha-D-GlcpNAc 0
                                                    alpha-D-Galp-(1->3)-alpha-D-Manp 0
                                                    alpha-D-Galp-(1->3)-beta-D-GlcpNAc + 0
                                                    alpha-D-Galp-(1->4)-D-Gal-OH 0
                                                    alpha-D-Galp-(1->4)-alpha-D-Glcp 0
                                                    alpha-D-Galp-(1->4)-alpha-L-Fucp 0
                                                    alpha-D-Galp-(1->4)-beta-D-Glcp + 0
                                                    alpha-D-Galp-(1->4)-beta-D-GlcpNAc 0
                                                    alpha-D-Galp-(1->6)-D-Glc-OH 0
                                                    alpha-D-Galp-(1->6)-alpha-D-Galp 0
                                                    alpha-D-Galp-(1->6)-alpha-D-Glcp 0
                                                    alpha-D-Galp-(1->6)-beta-D-Manp 0
                                                    alpha-D-GalpNAc-(1->3)-alpha-D-Galp + 0
                                                    alpha-D-Glcp-(1->3)-alpha-D-Galp + 0
                                                    alpha-D-Glcp-(1->6)-D-Gal-OH 0
                                                    alpha-D-Glcp-(1->6)-alpha-D-Galp + 0
                                                    alpha-D-GlcpN-(1->1)-alpha-D-Galp 0
                                                    alpha-D-Manp-(1->2)-alpha-D-Galp 0
                                                    alpha-D-galactose 1-phosphate 1
                                                    alpha-D-galactoside + 0
                                                    alpha-D-galactosyl group + 0
                                                    alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1<->1')-ceramide 0
                                                    alpha-L-Fucp-(1->2)-alpha-D-Galp 0
                                                    alpha-L-Fucp-(1->3)-alpha-D-Galp + 0
                                                    alpha-L-Fucp-(1->6)-alpha-D-Galp 0
                                                    beta-D-Galf-(1->3)-alpha-D-Galp 0
                                                    beta-D-Glcp-(1->3)-alpha-D-Galp 0
                                                    beta-D-Glcp-(1->6)-alpha-D-Galp 0
                                                    beta-L-Fucp-(1->2)-alpha-D-Galp 0
                                                    beta-L-Fucp-(1->3)-alpha-D-Galp 0
                                                    beta-L-Fucp-(1->4)-alpha-D-Galp + 0
                                                    penta-O-acetyl-alpha-D-galactose 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.